Health ❯ Healthcare ❯ Clinical Guidelines

Standard of Care

Radiotherapy Protocols Tagraxofusp-erzs Combination Therapy ER-positive Breast Cancer Treatment Protocols

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

The companies plan regulatory discussions after presenting the late-stage results at ESMO.

Roche’s Giredestrant Plus Everolimus Extends PFS in Phase 3 evERA for ER-Positive, HER2-Negative Breast Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial